UnitedHealth Group Incorporated Q2 2026 Earnings Recap

UnitedHealth Group’s shares rose modestly by 1.8% following mixed results: Medicare Advantage performed better than expected with improved margins and membership retention, but persistent commercial cost pressures and margin headwinds limited investor enthusiasm.

Key Takeaways

• Medicare Advantage enrollment now expected to decline by ~1.1 million in 2026, with margins forecasted to finish above 3%, reflecting effective benefit design and care management efforts.
• Medicare medical cost trends, while elevated, are running below initial expectations (~10%) due to internal initiatives and favorable external factors.
• Commercial medical cost trends remain stubbornly high, modestly exceeding 11%, driven by independent resolution process impacts and higher provider billing intensity.
• Medicaid performance was broadly in line with expectations but margins remain pressured as reimbursement rates lag medical cost trends.
• Optum businesses are tracking in line with plans, with momentum building in Optum Health and ongoing reinvestment at Optum Insight focused on AI-enabled modernization.